Birgit Girshick - 05 Jun 2026 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Reporting relationship: Chief Executive Officer
Issuer ticker: CRL
Reported as of: 05 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 16:21:53 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Birgit Girshick

Key filing fact

Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 08 Jun 2026.

Key facts

This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2026, 16:21.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001732091 Primary reporting owner

Girshick Birgit

Relationship: Chief Executive Officer
Address: C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON
Signature: /s/ Birgit Girshick
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Gift

Transaction value
Shares: -3,386
Change %: -8.6%
Price: $0.000000^*
Shares after: 36,013
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1

CRL transaction

Common Stock

Gift

Transaction value
Shares: +3,386
Change %: +8.4%
Price: $0.000000^*
Shares after: 43,803
Date: 05 Jun 2026
Ownership: Revocable Trust
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRL holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,722
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,722
Exercise price: $208.44

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects the exempt transfer pursuant to Rule 16a-13 of 3,386 shares held by the reporting person to a revocable trust controlled by the reporting person.